Citations

Showing 10 of 108015 citations.

Artificial Intelligence Support for Informal Patient Caregivers: A Systematic Review
Maniaci, Michael J. , Haider, Clifton R. , Pressman, Sophia M. , Haider, Syed Ali , Cowart, Jennifer B. , Forte, Antonio J. , Maniaci, Michael J , Cowart, Jennifer B , Forte, Antonio Jorge , Pressman, Sophia , Haider, Syed A , Borna, Sahar , Gomez-Cabello, Cesar A. , Demaerschalk, Bart M.

Mayo Clinic

Bioengineering | May 14, 2024 | Volume: 11 | Issue: 5 | Pages: 483

10.3390/bioengineering11050483 | PMID 38790350 Get It

This study aims to explore how artificial intelligence can help ease the burden on caregivers, filling a gap in current research and healthcare practices due to the growing challenge of an aging population and increased reliance on informal caregivers. We conducted a search with Google Scholar, PubMed, Scopus, IEEE Xplore, and Web of Science, focusing on AI and caregiving. Our inclusion criteria were studies where AI supports informal caregivers, excluding those solely for data collection. Adhering to PRISMA 2020 guidelines, we eliminated duplicates and screened for relevance. From 947 initially identified articles, 10 met our criteria, focusing on AI’s role in aiding informal caregivers. These studies, conducted between 2012 and 2023, were globally distributed, with 80% employing machine learning. Validation methods varied, with Hold-Out being the most frequent. Metrics across studies revealed accuracies ranging from 71.60% to 99.33%. Specific methods, like SCUT in conjunction with NNs and LibSVM, showcased accuracy between 93.42% and 95.36% as well as F-measures spanning 93.30% to 95.41%. AUC values indicated model performance variability, ranging from 0.50 to 0.85 in select models. Our review highlights AI’s role in aiding informal caregivers, showing promising results despite different approaches. AI tools provide smart, adaptive support, improving caregivers’ effectiveness and well-being.
Proteomic Identification of Plasma Proteins Associated with Future Dementia Development
Bornhorst, Joshua A. , Bornhorst, Joshua , Algeciras‐Schimnich, Alicia

Mayo Clinic

Clinical Chemistry | May 14, 2024 | Volume: 70 | Issue: 9 | Pages: 1092-1095

10.1093/clinchem/hvae004 | PMID 38741526 Get It

Senescent Macrophages Release Inflammatory Cytokines and RNA-Loaded Extracellular Vesicles to Circumvent Fibroblast Senescence
Laliberté, Camille , Bossé, Bianca, Bourdeau, Véronique , Prieto, Luis I. , Perron-Deshaies, Genève , Vuong, Nhung , Igelmann, Sebastian , Aguilar, Lisbeth C. , Baker, Darren J. , DesGroseillers, Luc , Ferbeyre, Gerardo , Baker, Darren J , Ferbeyre, Gerardo , Oeffinger, Marlene

Mayo Clinic

Biomedicines | May 14, 2024 | Volume: 12 | Issue: 5 | Pages: 1089

10.3390/biomedicines12051089 | PMID 38791051 Get It

Senescent cells, which accumulate with age, exhibit a pro-inflammatory senescence-associated secretory phenotype (SASP) that includes the secretion of cytokines, lipids, and extracellular vesicles (EVs). Here, we established an in vitro model of senescence induced by Raf-1 oncogene in RAW 264.7 murine macrophages (MΦ) and compared them to senescent MΦ found in mouse lung tumors or primary macrophages treated with hydrogen peroxide. The transcriptomic analysis of senescent MΦ revealed an important inflammatory signature regulated by NFkB. We observed an increased secretion of EVs in senescent MΦ, and these EVs presented an enrichment for ribosomal proteins, major vault protein, pro-inflammatory miRNAs, including miR-21a, miR-155, and miR-132, and several mRNAs. The secretion of senescent MΦ allowed senescent murine embryonic fibroblasts to restart cell proliferation. This antisenescence function of the macrophage secretome may explain their pro-tumorigenic activity and suggest that senolytic treatment to eliminate senescent MΦ could potentially prevent these deleterious effects.
Defining the “ideal state”: A primer on critical care pharmacy practice models
Smith, Susan , Nei, Andrea M.

Mayo Clinic

American Journal of Health-System Pharmacy | May 14, 2024 | Volume: 81 | Issue: 18 | Pages: 796-811

10.1093/ajhp/zxae135 | PMID 38741290 Get It

Abstract Purpose Critical care pharmacists (CCPs) have been clearly established as value-added members of the interprofessional team, and their contributions positively impact patient outcomes in the intensive care unit (ICU). Despite this, not every critically ill patient in the US receives care from a CCP and the model through which CCPs practice is variable, which has important implications. The purpose of this primer is to review current CCP models and discuss elements of the optimal CCP practice model. Summary Current CCP practice models are defined, including the drug processing and dispensing model, clinical pharmacy specialist model, integrated pharmacy generalist model, and hybrid model, as well as unit-based vs service-based models. The optimal CCP practice model considers the Triple Domain of CCP workload, which includes direct patient care, indirect patient care, and professional service. Elements of the ideal CCP practice model including 24/7/365 CCP services, unit- vs service-based models, prescriptive authority, operational support, and CCP-to-patient ratio are discussed. Other vital elements include dedicated offline time, use of appropriate workload metrics, development of career ladders, opportunities for professional development, and providing wellness resources. The ideal CCP practice model must also be considered through the lens of the patient and medical team, the CCP, the institution, and professional organizations. Strategies for optimizing current CCP practice models are provided, and application of optimal CCP practice model elements is explored through 5 case studies. Conclusion The optimal CCP practice model includes multiple elements and incorporates the viewpoints of patients, providers, CCPs, institutions, and professional organizations; this model will increase access of all ICU patients to CCPs, enhance the scope of CCP cognitive services, and ensure the economic sustainability of CCP practice while establishing CCP involvement in activities outside of patient care and in professional service.
Concomitant Sigmoid Diverticulitis and Periampullary Duodenal Diverticulitis Complicated by Lemmel Syndrome: A Case Report
Saha, Bibek , Jang, Samuel , Friesen, Joelle N. , Kalinoski-DuBose, Victoria , Verma, Anjul, Mundell, William

Mayo Clinic

Journal of Investigative Medicine High Impact Case Reports | May 14, 2024 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/23247096241253342 | PMID 38742534 Get It

Diverticular disease is a major cause of hospitalizations, especially in the elderly. Although diverticulosis and its complications predominately affect the colon, the formation of diverticula in the small intestine, most commonly in the duodenum, is well characterized in the literature. Although small bowel diverticula are typically asymptomatic, and diagnosed incidentally, a complication of periampullary duodenal diverticulum is Lemmel syndrome. Lemmel syndrome is an extremely rare condition whereby periampullary duodenal diverticula, most commonly without diverticulitis, leads to obstruction of the common bile duct due to mass effect and associated complications including acute cholangitis and pancreatitis. Here, we present the first case, to our knowledge, of periampullary duodenal diverticulitis complicated by Lemmel syndrome with concomitant colonic diverticulitis with colovesical fistula. Our case and literature review emphasizes that Lemmel syndrome can present with or without suggestions of obstructive jaundice and can most often be managed conservatively if caught early, except in the setting of emergent complications.
Mitral valve prolapse: arrhythmic risk during pregnancy and postpartum
Sabbag, Avi , Aabel, Eivind W. , Castrini, Anna Isotta , Siontis, Konstantinos C. , Duthoit, Guillaume , Asirvatham, Samuel J. , Sehrawat, Ojasay, Kirkels, Feddo P. , Rav, Moshe , Peichl, Petr , Lim, H. , Martins, Raphaël P. , Font, Jonaz , Truong, Nguyen Ngoc Khoi , Estensen, Mette E , Laredo, Mikael , Duthoit, Guillaume , Kirkels, Feddo P , Beinart, Roy , Peichl, Petr , Sohns, Christian , Haugaa, Kristina , Asirvatham, Samuel J , Martins, Raphael , Aabel, Eivind W , Sabbag, Avi , Nizard, J. , Rosendael, Philippe J. van , Beinart, Roy , Haugaa, Kristina H.

Mayo Clinic

European Heart Journal | May 14, 2024 | Volume: 45 | Issue: 20 | Pages: 1831-1839

10.1093/eurheartj/ehae224 | PMID 38740526 Get It

Abstract Background and Aims Arrhythmic mitral valve prolapse (AMVP) is linked to life-threatening ventricular arrhythmias (VAs), and young women are considered at high risk. Cases of AMVP in women with malignant VA during pregnancy have emerged, but the arrhythmic risk during pregnancy is unknown. The authors aimed to describe features of women with high-risk AMVP who developed malignant VA during the perinatal period and to assess if pregnancy and the postpartum period were associated with a higher risk of malignant VA. Methods This retrospective international multi-centre case series included high-risk women with AMVP who experienced malignant VA and at least one pregnancy. Malignant VA included ventricular fibrillation, sustained ventricular tachycardia, or appropriate shock from an implantable cardioverter defibrillator. The authors compared the incidence of malignant VA in non-pregnant periods and perinatal period; the latter defined as occurring during pregnancy and within 6 months after delivery. Results The authors included 18 women with AMVP from 11 centres. During 7.5 (interquartile range 5.8–16.6) years of follow-up, 37 malignant VAs occurred, of which 18 were pregnancy related occurring in 13 (72%) unique patients. Pregnancy and 6 months after delivery showed increased incidence rate of malignant VA compared to the non-pregnancy period (univariate incidence rate ratio 2.66, 95% confidence interval 1.23–5.76). Conclusions The perinatal period could impose increased risk of malignant VA in women with high-risk AMVP. The data may provide general guidance for pre-conception counselling and for nuanced shared decision-making between patients and clinicians.
Lower extremity purpura as an uncommon presentation of acute generalized exanthematous pustulosis (AGEP)
Akpala, Christeebella O. , Sokumbi, Olayemi , Comfere, Nneka I. , Yamanaka‐Takaichi, Mika , Sokumbi, Olayemi , Akpala, Christeebella O , Alavi, Afsáneh

Mayo Clinic

International Journal of Dermatology | May 14, 2024 | Volume: 63 | Issue: 12 | Pages: 1781-1782

10.1111/ijd.17247 | PMID 38741275 Get It

Anatomical Step-by-Step Dissection of Complex Skull Base Approaches for Trainees: Surgical Anatomy of the Translabyrinthine and Transcochlear Approaches
Perry, Avital , Carlstrom, Lucas P. , Alexander, A. Yohan , Leonel, Luciano, Nassiri, Ashley M. , Nguyen, Bachtri T. , Driscoll, Colin L. W., Link, Michael J. , Graffeo, Christopher S. , Peris‐Celda, Maria , Alexander, Alex Yohan, Nguyen, Bachtri , Graffeo, Christopher Salvatore , Alexander, A Yohan , Morris, Jonathan M.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | May 13, 2024 | Volume: 86 | Issue: 03 | Pages: 342-352

10.1055/s-0044-1786736 | PMID 40351883 Get It

Abstract Introduction Skull base neuroanatomy is traditionally learned through two-dimensional anatomical atlases, which while are of unquestionable value, lack the nuanced association of three-dimensional relationships between fundamental anatomical structures relevant to surgical approaches. Surgically focused step-by-step anatomical dissections can augment trainee learning of complex skull base techniques, particularly multistep and nuanced techniques such as translabyrinthine and transcochlear approaches. Methods Translabyrinthine and transcochlear approaches were performed on six sides of three formalin-fixed latex-injected specimens. The study objective was the completion and photo documentation of the steps involved in the approach in order to provide a comprehensive, intelligible, and anatomically oriented resource for multilevel trainees. Illustrative case examples were prepared to supplement approach dissections. Results The translabyrinthine and transcochlear approaches offer unique lateral windows through the temporal bone into the posterior fossa, providing excellent access to pathology at the petrous apex, internal auditory canal, Meckel's cave, and anterolateral brainstem. The transcochlear approach, which is an anterior extension of the translabyrinthine, particularly provides excellent exposure of the prepontine region and clivus. Important surgical considerations include patient position, temporal bone drilling and identification of critical landmarks, dural opening and identification of neurovascular structures, and reconstruction/closure techniques. Conclusion The translabyrinthine and transcochlear approaches are fundamental techniques for lateral skull base and posterior fossa pathologies. Both approaches are hearing-sacrificing but often require minimal to no cerebellar retraction and deliver unique visualization of prepontine neurovascular structures. This step-by-step approach guide provides a unique practical and high-yield surgically oriented learning resource for neurosurgery and otolaryngology trainees.
Mitral Regurgitation and Heart Failure with Preserved Ejection Fraction: Should we Treat the Muscle, the Valve, or Both?
Riccardi, Mauro , Borlaug, Barry A. , Inciardi, Riccardo M.

Mayo Clinic

European Journal of Heart Failure | May 13, 2024 | Volume: 26 | Issue: 6 | Pages: 1443-1445

10.1002/ejhf.3288 | PMID 38740731 Get It

Analgesia for the treatment of acute pancreatitis: a protocol for a systematic review and network meta-analysis
Subramani, Sriya S, Berg, Alaina , Král, L , Murad, M. Hassan , Smith, Abigail , Phillips, Anna Evans , Yadav, Dhiraj , Uç, Aliye , Berg, Alaina C , Murad, M Hassan , Imdad, Aamer

Mayo Clinic

BMJ Open | May 13, 2024 | Volume: 14 | Issue: 5 | Pages: e081971

10.1136/bmjopen-2023-081971 | PMID 38740508 Get It

Introduction Gastrointestinal hospitalisations in the USA cause over US$130 billion in expenditures, and acute pancreatitis is a leading cause of these hospitalisations. Adequate pain control is one of the primary treatment goals for acute pancreatitis. Though opioids are commonly used for analgesia in these patients, there have been concerns about short-term and long-term side effects of using opioids. Recently, non-opioid medications have been studied to treat pain in patients with acute pancreatitis. This systematic review and network meta-analysis aims to assess the comparative efficacy of analgesic medication for non-severe, acute pancreatitis. Methods and analysis We will search multiple electronic databases for randomised controlled trials that study pain management in patients with non-severe, acute pancreatitis. The intervention will be any analgesic for acute pancreatitis in the hospital setting. The comparison group will be patients who received a placebo or other active interventions for pain management. The primary outcomes of interest include pain scores and the need for supplementary analgesia. The secondary outcomes will be serious adverse events, local complications, progression to severe pancreatitis, transfer to the intensive care unit, length of hospitalisation, time to start enteral feeds, 30-day all-cause mortality and Quality of Life Scale scores. If sufficient homogeneity exists among included studies, the findings will be pooled using a traditional pairwise and network meta-analysis. The risk of bias in randomised control trials will be evaluated using the Cochrane Risk of Bias Tool 2.0. The Grading of Recommendations, Assessment, Development, and Evaluation approach will be used to report the certainty of evidence. Ethics and dissemination This systematic review will not involve direct contact with human subjects. The findings of this review will be published in a peer-reviewed journal. They will give healthcare providers a better awareness of the optimal analgesic medication for pain treatment in non-severe, acute pancreatitis.